Revenue increased 23.9%
Revenue changed +23.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +23.9% from the comparable as-filed period.
Cash & equivalents changed -46.6% from the comparable as-filed period.
Gross profit changed +22.6% from the comparable as-filed period.
Inventory changed +21.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -237 basis points from the comparable as-filed period.
Research & development changed -40.5% from the comparable as-filed period.
Selling, general & administrative changed +28.9% from the comparable as-filed period.
Debt changed -12.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -12.4% from the comparable as-filed period.
Operating income changed -12.4% from the comparable as-filed period.
Stock-based compensation changed -13.2% from the comparable as-filed period.
Gross margin changed -57 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.